J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 85 (2004), 2937-2942; DOI 10.1099/vir.0.80149-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandhasin, C.
Right arrow Articles by Levy, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandhasin, C.
Right arrow Articles by Levy, L. S.
Agricola
Right arrow Articles by Chandhasin, C.
Right arrow Articles by Levy, L. S.
© 2004 Society for General Microbiology

Short Communication

Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster

Chandtip Chandhasin1,2,3, Patricia Lobelle-Rich1,3 and Laura S. Levy1,2,3

1 Department of Microbiology and Immunology, Tulane University Health Sciences Center, 1430 Tulane Avenue SL-38, New Orleans, LA, USA
2 Program in Molecular and Cellular Biology, Tulane University Health Sciences Center, 1430 Tulane Avenue SL-38, New Orleans, LA, USA
3 Tulane Cancer Center, Tulane University Health Sciences Center, 1430 Tulane Avenue SL-38, New Orleans, LA, USA

Correspondence
Laura S. Levy
llevy{at}tulane.edu

Feline leukaemia virus (FeLV)-945 was previously identified in natural multicentric lymphomas and contains a 21 bp tandem triplication in the LTR. In the present study, FeLV LTR variation was examined in the cohort from which FeLV-945 was identified. The objectives of the study were to evaluate FeLV LTR variation within the cohort, to determine whether the FeLV-945 LTR was associated uniquely with multicentric lymphoma and to evaluate functional attributes that may have contributed selective advantage to the predominant LTR variants observed. T-cell tumours uniformly contained LTRs with duplicated enhancer sequences, although enhancer duplications conferred little transcriptional advantage. Non-T-cell malignant, proliferative and degenerative diseases contained LTRs with two, three or four tandemly repeated copies of the 21 bp sequence originally identified in FeLV-945. While the length and termini of enhancer duplications were variable, the 21 bp repeat unit was invariant. Triplication of the 21 bp repeat conferred the optimal replicative advantage in feline cells.

The GenBank/EMBL/DDBJ accession numbers for the sequences determined in this work are AY374181AY374224.




This article has been cited by other articles:


Home page
J. Virol.Home page
S. L. Finstad, N. Rosenberg, and L. S. Levy
Diminished Potential for B-Lymphoid Differentiation after Murine Leukemia Virus Infection In Vivo and in EML Hematopoietic Progenitor Cells
J. Virol., July 1, 2007; 81(13): 7274 - 7279.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Chandhasin, P. N. Coan, I. Pandrea, C. K. Grant, P. A. Lobelle-Rich, A. Puetter, and L. S. Levy
Unique Long Terminal Repeat and Surface Glycoprotein Gene Sequences of Feline Leukemia Virus as Determinants of Disease Outcome
J. Virol., May 1, 2005; 79(9): 5278 - 5287.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Chandhasin, P. N. Coan, and L. S. Levy
Subtle Mutational Changes in the SU Protein of a Natural Feline Leukemia Virus Subgroup A Isolate Alter Disease Spectrum
J. Virol., February 1, 2005; 79(3): 1351 - 1360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2004 by the Society for General Microbiology.